NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
MilitaryCrisisStrikesTrumpFebruaryWinDiplomaticOscarNewsDigestTimelineTariffsFundingInfrastructureAdditionalCourtArrestedGovernmentClimateTrump'sGreenlandDaysAnnouncesIranian
MilitaryCrisisStrikesTrumpFebruaryWinDiplomaticOscarNewsDigestTimelineTariffsFundingInfrastructureAdditionalCourtArrestedGovernmentClimateTrump'sGreenlandDaysAnnouncesIranian
All Articles
Abbott Seeks $20 Billion in US Bond Sale for M&A
Bloomberg
Published about 5 hours ago

Abbott Seeks $20 Billion in US Bond Sale for M&A

Bloomberg · Feb 23, 2026 · Collected from RSS

Summary

Abbott Laboratories is looking to raise about $20 billion from a bond sale to help fund its acquisition of cancer-screening company Exact Sciences Corp., marking one of the biggest offerings to hit the market this year.

Share this story
Read Original at Bloomberg

Related Articles

Bloombergabout 1 hour ago
Retailers Win Tariff Relief on Supreme Court Ruling

Gap, Aritzia and Urban Outfitters are among apparel retailers that should see margins expand, with the US' global tariff set at 15% -- vs. an average 20% for the sector -- after the Supreme Court struck down President Donald Trump's sweeping levies. Trump revised the blanket rate less than a day after announcing a 10% level, and is expected to pursue higher tariffs on China under Section 301. Bloomberg's Mary Ross Gilbert joins to discuss her research on the retailer sector and how tariffs are effecting certain brands. (Source: Bloomberg)

Bloombergabout 1 hour ago
Trump Takes Anti-China Cursade to Chile Ahead of Latin America Summit in Miami

Chile for decades finessed the geopolitical rivalry between China, its top trading partner, and the US, its leading foreign investor.

Bloombergabout 1 hour ago
Eversource Set to Raise $1.5 Billion From Its First Hybrid Bonds

Eversource Energy is set to raise $1.5 billion from selling its first hybrid bonds, as the New England utility operator looks to refinance debt.

Bloombergabout 1 hour ago
Novo Next-Generation Obesity Shot Falls Short of Lilly Rival

Novo Nordisk’s next-generation obesity shot delivered less weight loss than Eli Lilly rival blockbuster in yet another blow to the Danish company’s attempts to regain lost ground in the weight-loss market. People treated with a standard dose of Novo’s CagriSema in a trial achieved 20.2% weight loss after 84 weeks, compared with 23.6% for Lilly’s tirzepatide. Sam Fazeli of Bloomberg Intelligence joins to discuss. He also breaks down how Merck is splitting its main pharmaceutical unit in two in an effort to better highlight the parts of the business that are growing, as it stares down a patent cliff for its best-selling cancer drug Keytruda. (Source: Bloomberg)

Bloombergabout 1 hour ago
Exchange Income Corp. Is Preparing Its First Bond Sale

Exchange Income Corp., which acquires and operates aerospace, aviation and manufacturing businesses, is preparing to sell as much as C$500 million ($365 million) of bonds in its first note sale, according to people familiar with the matter.

Bloombergabout 1 hour ago
ECB’s Lagarde Says Europe Can Still Benefit Greatly From AI

European Central Bank President Christine Lagarde said Europe can still capitalize on artificial intelligence, even without leading the way in developing frontier models.